Filing Details
- Accession Number:
- 0001562180-22-006705
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-16 17:34:10
- Reporting Period:
- 2022-09-15
- Accepted Time:
- 2022-09-16 17:34:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1395937 | Syndax Pharmaceuticals Inc | SNDX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314595 | Dennis Podlesak | C/O Syndax Pharmaceuticals, Inc. 35 Gatehouse Drive, Building D, Floor 3 Waltham MA 02451 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-15 | 66,840 | $6.32 | 142,603 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-15 | 66,840 | $24.20 | 75,763 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-09-16 | 5,419 | $6.32 | 81,182 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-16 | 5,419 | $23.43 | 75,763 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-09-16 | 6,556 | $6.35 | 82,319 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-16 | 6,556 | $23.43 | 75,763 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to buy) | Disposition | 2022-09-15 | 66,840 | $0.00 | 66,840 | $6.32 |
| Common Stock | Stock Options (Right to buy) | Disposition | 2022-09-16 | 6,556 | $0.00 | 6,556 | $6.35 |
| Common Stock | Stock Options (Right to buy) | Disposition | 2022-09-16 | 5,419 | $0.00 | 5,419 | $6.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-09-15 | No | 4 | M | Direct | |
| 0 | 2024-12-18 | No | 4 | M | Direct | |
| 0 | 2024-09-15 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 192,600 options to purchase shares of common stock that are vested and immediately exercisable and no unvested options to purchase shares of common stock.
- The sale prices ranged from $23.37 to $24.64
- The sale prices ranged from $22.96 to $24.07
- This option is fully vested.
Billionaire Hedge Funds
